Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors

被引:43
作者
Tamura, SY [1 ]
Weinhouse, MI [1 ]
Roberts, CA [1 ]
Goldman, EA [1 ]
Masukawa, K [1 ]
Anderson, SM [1 ]
Cohen, CR [1 ]
Bradbury, AE [1 ]
Bernardino, VT [1 ]
Dixon, SA [1 ]
Ma, MG [1 ]
Nolan, TG [1 ]
Brunck, TK [1 ]
机构
[1] Corvas Int Inc, Dept Med Chem, San Diego, CA 92121 USA
关键词
D O I
10.1016/S0960-894X(00)00149-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Solid- and solution-phase synthesis of peptidomimetic inhibitors of urokinase-type plasminogen activator based on the sequence dSerAlaArg-al are described. The biological activities of these unique inhibitors are reported herein. Carbonate prodrugs were prepared and tested as potential drug delivery systems. (C) 2000 Published by Elsevier Science Ltd.
引用
收藏
页码:983 / 987
页数:5
相关论文
共 26 条
[1]   Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model [J].
Alonso, DF ;
Farias, EF ;
Ladeda, V ;
Davel, L ;
Puricelli, L ;
Joffe, EBD .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 40 (03) :209-223
[2]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[3]  
2-Z
[4]   ANGIOGENESIS INHIBITION - A REVIEW [J].
AUERBACH, W ;
AUERBACH, R .
PHARMACOLOGY & THERAPEUTICS, 1994, 63 (03) :265-311
[5]  
Bridges A J, 1993, Bioorg Med Chem, V1, P403, DOI 10.1016/S0968-0896(00)82150-1
[6]  
Jankun J, 1997, CANCER RES, V57, P559
[7]   Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay [J].
Kim, J ;
Yu, W ;
Kovalski, K ;
Ossowski, L .
CELL, 1998, 94 (03) :353-362
[8]  
KUCINSKI CS, 1968, CLIN INVESTIGATOR, V47, P1238
[9]   Plasminogen activators and matrix metalloproteinases in angiogenesis [J].
Mignatti, P ;
Rifkin, DB .
ENZYME & PROTEIN, 1996, 49 (1-3) :117-137
[10]   THE ROLE OF PROTEINASES IN CELLULAR INVASIVENESS [J].
MULLINS, DE ;
ROHRLICH, ST .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 695 (3-4) :177-214